Trevena stock held at USD 0.01 as volume reached 257 shares
Published on 10/07/2026 at 03:20 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS
Trevena stock was last at USD 0.01 on OTC Markets OTCPK on October 6, 2026 at 3:24 p.m. ET, with 257 shares changing hands and a 0.00 percent move from the USD 0.01 prior close. The dated quote brings the company's trading liquidity and clinical pipeline into view for investors following the biotechnology business.
OTC trading stays flat
The October 6 quote showed USD 0.01 for both the latest price and the prior close, producing a displayed daily change of 0.00 percent. Volume reached 257 shares, compared with an average volume of 149 shares, making the session's activity 108 shares higher than that average.
The stock's market profile is distinct from a standard Nasdaq listing. Yahoo Finance identifies TRVN as an OTC Markets OTCPK security quoted in USD, while Trevena's investor page lists a Nasdaq delisting notification dated October 4, 2024.
Historical results show losses
The most recent financial period displayed on the company investor page is the quarter ended September 30, 2024, with results released on November 7, 2024. Trevena identifies Q3 2024 as its latest financial results on that page.
Historical Q3 2024 data from Yahoo Finance show revenue of USD 283,000, earnings of negative USD 4.94 million and a profit margin of negative 1,745.23 percent. GAAP EPS was USD -5.79 against a USD -7.75 estimate, a USD 1.96 difference in the company's favor on the reported measure. These figures are historical context for the October 6, 2026 market quote.
Pipeline defines the business
Trevena describes itself as a biopharmaceutical company developing medicines for central nervous system disorders. Its approved product is OLINVYK, while the company lists TRV250, TRV734 and TRV045 among its investigational programs.
The company investor page describes OLINVYK as an FDA-approved treatment and identifies TRV734 as a program for opioid use disorder maintenance treatment. It also describes TRV045 as an S1P receptor modulator aimed at non-opioid approaches for chronic pain and other central nervous system disorders.
Trevena stock carries OTC status
The October 4, 2024 Nasdaq delisting notification on Trevena's investor page provides the listing context for the current OTC Markets quotation. With the October 6 price unchanged from the prior close and volume at 257 shares, trading data remain the clearest current market signal for Trevena stock.
Trevena stock key data
- Company: Trevena, Inc.
- Ticker: TRVN
- Trading venue: OTC Markets OTCPK
- Price (as of October 6, 2026, 3:24 p.m. ET): USD 0.01
- Sector / Industry: Healthcare / Biotechnology
